Literature DB >> 2578574

MC29 virus-coded protein occurs as monomers and dimers in transformed cells.

J P Bader, D A Ray.   

Abstract

The MC29 virus-coded protein p110gag-myc was found exclusively in the nucleus of transformed Japanese quail (Q8) cells, and time course experiments indicated that the protein had a half-life of about 30 min. When extracts of either Q8 or chicken embryo cells infected with MC29 virus were prepared with nondenaturing detergents and then sedimented in sucrose gradients, p110 was found in the fractions expected to contain monomers (5.9S), dimers (9.3S), or mixtures of the two. The same extracts treated with denaturing detergent (0.2% sodium dodecyl sulfate) exhibited p110 only in fractions expected for the monomeric protein, but beta-mercaptoethanol had no effect on the original distribution. Gradients prepared with 0.5 or 1.0 M NaCl failed to dissociate the faster-sedimenting form. No other protein or polyribonucleotide which could increase the sedimentation rate of p110 was found, and neither RNase nor DNase altered the sedimentation pattern of p110 in nondenatured extracts. A reassociation of monomeric p110 into dimers discernible by gel electrophoresis was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578574      PMCID: PMC254664     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  A src-related 120,000-dalton protein expressed in an avian sarcoma virus-transformed rat cell line.

Authors:  R Hirai; H Mitsui; R Ishizaki
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

2.  Biochemical characterization of transformation-specific proteins of acute avian leukemia and sarcoma viruses.

Authors:  K Moelling; M K Owada; I Greiser-Wilke; T Bunte; P Donner
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

3.  RNA and protein encoded by MH2 virus: evidence for subgenomic expression of v-myc.

Authors:  C Pachl; B Biegalke; M Linial
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

4.  Relationship of oligomerization to enzymatic and DNA-binding properties of the SV40 large T antigen.

Authors:  M K Bradley; J D Griffin; D M Livingston
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

5.  Nucleotide sequence analysis of the proviral genome of avian myelocytomatosis virus (MC29).

Authors:  E P Reddy; R K Reynolds; D K Watson; R A Schultz; J Lautenberger; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

Review 6.  DNA-binding proteins.

Authors:  Y Takeda; D H Ohlendorf; W F Anderson; B W Matthews
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

7.  Identification of the c-myc oncogene product in normal and malignant B cells.

Authors:  A Giallongo; E Appella; R Ricciardi; G Rovera; C M Croce
Journal:  Science       Date:  1983-10-28       Impact factor: 47.728

8.  Nuclear location of the putative transforming protein of avian myelocytomatosis virus.

Authors:  H D Abrams; L R Rohrschneider; R N Eisenman
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

9.  Two virus-specific rna species are present in cells transformed by defective leukemia virus OK10.

Authors:  D J Chiswell; G Ramsay; M J Hayman
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

10.  Decreased DNA-binding ability of purified transformation-specific proteins from deletion mutants of the acute avian leukemia virus MC29.

Authors:  P Donner; T Bunte; I Greiser-Wilke; K Moelling
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  2 in total

1.  Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene.

Authors:  T P Mäkelä; K Saksela; K Alitalo
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

2.  Sequence-specific DNA binding by Myc proteins.

Authors:  E Kerkhoff; K Bister; K H Klempnauer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.